Search filters

Filters
Clear All

Phase

  • 2
  • 2
  • 1
  • 9
  • 16
  • 2
  • 6
  • 1
  • 9

Found 16 Obesity trials

A listing of Obesity medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 FIT-PLESE: A study for overweight women with unexplained infertility, seeking pregnancy report Trial 3
K
KRISTI M. LELIONIS
18 years - 40 years
Non-Binary
FIT-PLESE is a research study to find out the effects of lifestyle modification in obese women with unexplained infertility. Eligible participants will be randomized to either an Intensive Lifestyle Modification Program or a Standard Physical Activity Program for 16 weeks, followed by fertility treatment with ovarian stimulation and intrauterine insemination.
 Research Study for women with PCOS (Polycystic ovary syndrome)
18 years - 45 years
Female
Healthy women ages 18-45 with Polycystic Ovary Syndrome (PCOS) are invited to screen for a study participation in an investigational drug study
 EFFICACY AND SAFETY OF A ONCE-WEEKLY INJECTABLE MEDICINE IN PARTICIPANTS WITH OVERWEIGHT OR OBESITY. (REDEFINE 1)
J
James David
18 years - 100 years
All genders
Phase 1
This study has 2 parts: The first part is the main study and the second part is the extension study. During the main study participants will receive 1 of 4 study medicines. If participants continue in the extension study, they will not receive any study medicine during the extension. The …
 Does vaginal delivery of combined hormonal contraception affect the risk of metabolic syndrome in overweight/obese women with PCOS?
99 years or below
Female
Please see attached protocol under Section 1, titled "Background and Study Rationale".
99 years or below
All genders
Obesity is strongly regulated by energy expenditure, but the variables regulating individual levels of energy expenditure in the human population remain unknown. This study examines the parameters regulating energy expenditure at rest and during exercise in healthy adults across the lifespan. Participants will fill out a questionnaire and provide blood, …
 Extreme Phenotypes and Obstructive Sleep Apnea
18 years - 99 years
All genders
The purpose of this study is to understand the relationship between obesity and obstructive sleep apnea. Obstructive sleep apnea typically causes daytime sleepiness and fragmented (broken up) sleep. Obesity is thought to be the most important risk factor for sleep apnea, yet we currently do not understand how obesity increases …
 Randomized Controlled Trial Examining the Effects of Meal Timing Among Obese Individuals
21 years - 50 years
All genders
Normal 0 false false false EN-US X-NONE X-NONE We are currently screening for this study, but all in-person visits are on hold until the COVID-19 virus state of emergency is lifted. The timing of food consumption is now recognized as a significant contributor to body weight regulation and metabolic functioning. …
18 years - 40 years
Female
OCPs increase the risk of MetS specifically by producing an atherogenic lipoprotein phenotype, increasing blood pressure and/ or body weight while metformin modestly decreases MetS risk by decreasing body weight and improving lipid phenotype. The combination of OCP and metformin (OCP, through lowering androgens, and metformin, through improvement in insulin …
 Daily Liraglutide for Nicotine Dependence
18 years - 99 years
All genders
We are currently recruiting smokers who are interested in quitting for a research study that involves taking a medication called liraglutide. Liraglutide is also marketed under the name Saxenda®.Liraglutide is an injectable medicine that may help some adults with who are overweight or obese lose weight and keep the weight …
 A Better FIT! Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment
21 years - 70 years
All genders
A 28-week research study is being conducted that is designed to help all participants lose weight. All participants will receive lifestyle modification (diet, exercise, and behavioral treatment). Participants who do not lose weight with lifestyle modification alone also will be prescribed an FDA-approved weight loss medication (phentermine) or placebo.
1 - 10 of 16